CareTalk: Healthcare. Unfiltered.

Send us Fan MailDoctors now need an estimated 30 hours a day to complete every clerical task asked of them. They are compensated not for the care they deliver but for the care they document. That gap is where physician burnout lives, and where AI has the most to offer.Dr. Shiv Rao, Co-Founder and CEO of Abridge, joins host John Driscoll to discuss how an ambient AI platform now deployed across more than 300 health systems is giving clinicians back the time and presence to actually practice medicine, and why the next frontier for this technology goes beyond documentation into real-time clinical decision support at the point of care.🎙️⚕️ABOUT DR. SHIV RAOShiv Rao, MD, is the Founder and CEO of Abridge. Shiv is a practicing cardiologist at UPMC. He previously led the provider-facing investment portfolio for UPMC where he invested in startups, and also helped fund a Machine Learning in Health program at Carnegie Mellon University. Shiv completed his medical education and training at the University of Michigan and the University of Pittsburgh School of Medicine. He received his BA from Carnegie Mellon, where he also programmed virtual synthesizers, and skateboarded in IMAX movies.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHVisit us on the webFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailAmerican healthcare still runs on fax machines, paper forms, and reimbursement models built for reactive sick care. Meanwhile, patients are connecting wearables to AI chatbots, ordering their own labs, and triaging themselves without ever seeing a physician.Dr. Daniel Kraft, Founder of Digital.Health and NextMed Health, joins host John Driscoll to discuss why the consumer is pulling healthcare into the future faster than institutions can follow, and what continuous, AI-powered, multimodal health monitoring could mean for the 500 million people who cannot get timely access to a primary care doctor today.🎙️⚕️ABOUT DANIEL KRAFT, M.D.Daniel Kraft is a Stanford- and Harvard-trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research, and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, and in 2011 founded NextMed Health (previously called Exponential Medicine), a program and community that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He serves as Chair of the XPRIZE Pandemic & Health Alliance. Daniel is an Adjunct Professor in the Department of Medicine at Stanford University School of Medicine.He is often called upon to speak to the future of health, medicine, and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations. He has multiple scientific publications (including in Nature and Science) and has done medical device, immunology, and stem cell-related work through NIH-funded faculty positions at Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at UCSF. He is the founder of Digital.Health, is a Kaufman Fellow, and an Aspen Institute Health Innovation Fellow. 🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHVisit us on the webFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailMost health tech companies do not fail because their product does not work. They fail because they never defined what success looked like before the pilot ended and the budget conversation began.Dan Galles, Partner at Allumia Ventures, joins host David E. Williams to discuss what 16 exits over a decade investing from inside Providence Health System revealed about what it actually takes to go from pilot to enterprise contract, and why the care model transformation AI is enabling may be the most important investment theme in healthcare right now.🎙️⚕️ABOUT DAN GALLESDan joined Allumia Ventures in 2015. He focuses on investments in the healthcare information technology, healthcare services, and medical device sectors. For over 20 years, he has been investing in and partnering with management teams of early- and growth-stage companies in the healthcare industry. Prior to joining Allumia, Dan was a partner at HLM Venture Partners, where he led or co-led investments in 14 companies. Before HLM, he was an associate at the venture capital firm J.H. Whitney and Co. and an analyst in the healthcare investment banking group at Alex. Brown & Sons. He holds an MBA from the Kellogg School at Northwestern University and a BS in Economics from The Wharton School. Dan lives in the San Francisco Bay Area with his wife and three kids, and is an avid sports fan including playing golf, pick-up basketball, and pickleball with his friends and family.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHVisit us on the webFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA national standard for reproductive health data privacy is not coming. The political divide is too wide and the parties are too far apart.In this clip from our episode “State Health Data Laws Are a Patient Safety Problem”, host David E. Williams and Leigh Burchell, Vice President of Policy and Public Affairs at Altera Digital Health, break down why a federal fix to the state health data patchwork is unlikely and what HIPAA was never built to handle in the first place.Listen to the full episode here🎙️⚕️ABOUT LEIGH BURCHELLWinner of the Changemaker in Health (Policy) and Most Influential Women in Health IT awards and a long-time leader with the EHR Association, I am a passionate advocate about the opportunities that exist for health outcomes improvement and cost containment thanks to the country's widespread adoption of health information technology. I work to ensure policy makers are educated and aware of the implications of potential and current laws and regulations, maximizing long-term relationships with those in both government and other stakeholder groups across the industry. I undertake efforts working on behalf of Altera, as well as through both industry non-governmental organizations and our trade association.   Specialties:  Healthcare Information Technology / Electronic Health Records (EHR) Payment and Delivery System Reform in Healthcare Legislative Relationships Regulatory Analysis and Response Physician Perspective in EHR Projects, HIE Settings Health Information Exchange (HIE) Health Equity / Social Determinants of Health Best Practices for HIE Governance Community-wide EHR Adoption🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHVisit us on the webFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA patient's right to control their own health data now depends almost entirely on which state they live in or happen to seek care in. The patchwork is growing, and the clinical and compliance consequences are catching up fast.Leigh Burchell, Vice President of Policy and Public Affairs at Altera Digital Health and Chair of the Electronic Health Record Association, joins host David E. Williams to discuss why states moving in opposite directions on sensitive health data are creating real patient safety risks, and what it costs EHR vendors in hundreds to thousands of engineering hours every time another state writes its own version of the rules.🎙️⚕️ABOUT LEIGH BURCHELLWinner of the Changemaker in Health (Policy) and Most Influential Women in Health IT awards and a long-time leader with the EHR Association, I am a passionate advocate about the opportunities that exist for health outcomes improvement and cost containment thanks to the country's widespread adoption of health information technology. I work to ensure policy makers are educated and aware of the implications of potential and current laws and regulations, maximizing long-term relationships with those in both government and other stakeholder groups across the industry. I undertake efforts working on behalf of Altera, as well as through both industry non-governmental organizations and our trade association.   Specialties:  Healthcare Information Technology / Electronic Health Records (EHR) Payment and Delivery System Reform in Healthcare Legislative Relationships Regulatory Analysis and Response Physician Perspective in EHR Projects, HIE Settings Health Information Exchange (HIE) Health Equity / Social Determinants of Health Best Practices for HIE Governance Community-wide EHR Adoption🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.🩺 THIS EPISODE IS BROUGHT TO YOU BY:Vector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA year ago, if you went to a healthcare security conference, AI was still on the horizon. Interesting, a little speculative, maybe useful for writing better phishing emails. But not anymore. There are documented cases where an attacker handed an AI agent stolen credentials and the agent ran the entire attack by itself. It can include hundreds of steps, from breaking in, harvesting credentials, mapping the network, encrypting everything, and leaving the ransom note.David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break it all down, examining what a documented 600-step autonomous AI attack means for health system security teams and why the most effective defense still comes down to fundamentals.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.🩺 THIS EPISODE IS BROUGHT TO YOU BY:Vector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA cancer diagnosis used to be enough to qualify as medically frail and exempt from Medicaid work requirements. A new federal rule says it no longer is, and nobody has defined what will be enough instead.In this clip from our episode “The Hidden Cost of Medicaid Work Requirements”, hosts David E. Williams and John Driscoll break down the last-minute rule change narrowing the definition of medical frailty and why 25 states say the federal government has gone beyond what Congress ever authorized.Listen to the full episode here🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailMedicaid work requirements take effect in every expansion state by January 1, 2027. But half the states just sued to stop the rules that govern them. They’re challenging a new federal rule that narrows who counts as “medically frail” and adds paperwork for people trying to prove they’re exempt. We’ll discuss what the fight means for coverage, providers, and for the states preparing to implement.In our latest episode, David E. Williams (President, Health Business Group) and John Driscoll (Chairman, UConn Health) dig into what these cuts will really cost. They break down the CBO's projections for coverage and dollars over the next decade, and why a last-minute federal rule narrowing the definition of "medical frailty" may be the most consequential, and least understood, piece of the whole debate.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 🩺 THIS EPISODE IS BROUGHT TO YOU BY:Vector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailMedicaid and Medicare used to pay first and chase fraud later. That model is changing fast, and the providers who haven't adapted are about to feel it.In this clip from our episode “AI and The Future Of Behavioral Health”, host John Driscoll and Alon Joffe, Co-Founder and CEO of Eleos Health, break down why the shift to audit-first payment in Medicaid and Medicare is an existential threat for behavioral health organizations already operating on razor-thin margins.Listen to the full episode here🎙️⚕️ABOUT ALON JOFFEAlon Joffe is the Co-Founder and CEO of Eleos Health, a behavioral health technology company that uses AI to automate clinical documentation and generate insights from provider-client conversations. Since its founding in 2020, Eleos has raised $28 million and expanded to more than 25 community mental health centers across 15 states.Inspired by close friends who experienced PTSD following his military service in an elite Israeli Air Force unit, Alon focuses on using technology to improve behavioral healthcare delivery. Before founding Eleos, he launched two companies and worked on the investment team at a Boston-based venture capital firm. He holds a B.A. and an LL.B., summa cum laude, from Reichman University and was named to Forbes 30 Under 30.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailMore than 160 million Americans live in areas with a shortage of mental health providers. The clinicians who do show up are spending hours on documentation, compliance, and eligibility work that has nothing to do with patient care.Alon Joffe, Co-Founder and CEO of Eleos Health, joins host John Driscoll to discuss how AI is reducing administrative burden for behavioral health clinicians and why workflow efficiency is becoming critical for community health centers facing Medicaid funding challenges.🎙️⚕️ABOUT ALON JOFFEAlon Joffe is the Co-Founder and CEO of Eleos Health, a behavioral health technology company that uses AI to automate clinical documentation and generate insights from provider-client conversations. Since its founding in 2020, Eleos has raised $28 million and expanded to more than 25 community mental health centers across 15 states.Inspired by close friends who experienced PTSD following his military service in an elite Israeli Air Force unit, Alon focuses on using technology to improve behavioral healthcare delivery. Before founding Eleos, he launched two companies and worked on the investment team at a Boston-based venture capital firm. He holds a B.A. and an LL.B., summa cum laude, from Reichman University and was named to Forbes 30 Under 30.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone. Learn what PIM Health is building hereVector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics. Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHVisit us on the webFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA triplet birth in the United States costs roughly $577,000. A twin birth runs about $155,000. For a self-insured employer, that cost hits the bottom line directly.In this clip from our episode “Making Fertility Benefits An Employer Priority”, host David E. Williams and David Stern, CEO of Kindbody, break down how Kindbody puts skin in the game with employers through contractual guarantees on multiple birth rates, miscarriage rates, and time to care.Listen to the full episode here🎙️⚕️ABOUT DAVID STERNDavid Stern has over 30 years of women's health experience with a career focused primarily on the fertility industry. Most recently he served as CEO of Boston IVF, one of the largest IVF center networks in the United States, which became part of IVIRMA Global, the largest fertility group in the world, in 2024. Prior to that he was CEO of Symbiomix Therapeutics, leading the company from development stage through commercial launch before its acquisition by Lupin Pharmaceuticals in 2017. He has held executive roles at Merck Serono as SVP and Head of the Global Fertility Business Franchise, and has built commercial teams and partnerships at Celmatix, Ohana, and OvaScience. He also served on the board of California Cryobank and began his career in women's health at Organon Pharmaceutics. He holds an MBA from the F.W. Olin School of Business at Babson College and a BS in Biology from Brandeis University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFertility benefits have gone from a Silicon Valley recruiting perk to a boardroom priority in under a decade. Employers are no longer just offering access. They are demanding measurable outcomes, transparent costs, and clinical accountability.David Stern, CEO of Kindbody, joins host David E. Williams to discuss why the vertically integrated model of combining a fertility benefit manager with owned clinics is producing better outcomes for employers and patients alike, and what it means that a company serving Walmart employees in rural Arkansas is now one of the most important access stories in American reproductive medicine.🎙️⚕️ABOUT DAVID STERNDavid Stern has over 30 years of women's health experience with a career focused primarily on the fertility industry. Most recently he served as CEO of Boston IVF, one of the largest IVF center networks in the United States, which became part of IVIRMA Global, the largest fertility group in the world, in 2024. Prior to that he was CEO of Symbiomix Therapeutics, leading the company from development stage through commercial launch before its acquisition by Lupin Pharmaceuticals in 2017. He has held executive roles at Merck Serono as SVP and Head of the Global Fertility Business Franchise, and has built commercial teams and partnerships at Celmatix, Ohana, and OvaScience. He also served on the board of California Cryobank and began his career in women's health at Organon Pharmaceutics. He holds an MBA from the F.W. Olin School of Business at Babson College and a BS in Biology from Brandeis University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereVector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhat if the companies profiting most from healthcare's data problem are also the ones best positioned to explain why it needs to be solved?In this clip from our episode “Health Data Is Broken And We're Paying For It”, host John Driscoll and Michael Meucci, CEO of Arcadia, break down why the free market has proven it cannot fix healthcare data fragmentation on its own, and what becomes possible when health systems stop spending so much money just moving data around.Listen to the full episode here🎙️⚕️ABOUT MICHAEL MEUCCIMichael Meucci is President and CEO of Arcadia, a healthcare data and technology company, where he has built a 15+ year career spanning roles as CEO, COO, and Chief Growth Officer. He has been central to Arcadia's growth in value-based care, leading the evolution of its technology platform to enable data-driven decision-making and improved patient and financial outcomes for payers and providers. He holds board positions at healthcare AI platform N1 Health and Fenway Health, and serves as an advisor to value-based care enabler Guidehealth. Named a Rising Star by Becker's Hospital Review and a 40 Under 40 by Boston Business Journal, he is a member of the Forbes Technology Council and a frequent media commentator on digital health. He holds a BA in Economics and Entrepreneurial Leadership from Tufts University.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailAmerican healthcare spends an estimated $110 per member per month just to administer itself, before a single service is ever delivered. Most of that cost exists because health data still cannot move freely between the systems that need it.Michael Meucci, CEO of Arcadia, joins host John Driscoll to discuss why two decades of interoperability policy have failed to solve the data fragmentation problem facing health systems and payers, and why liberating that data and redirecting the administrative spend it currently requires could be the single biggest lever available for improving both the cost and quality of American healthcare.🎙️⚕️ABOUT MICHAEL MEUCCIMichael Meucci is President and CEO of Arcadia, a healthcare data and technology company, where he has built a 15+ year career spanning roles as CEO, COO, and Chief Growth Officer. He has been central to Arcadia's growth in value-based care, leading the evolution of its technology platform to enable data-driven decision-making and improved patient and financial outcomes for payers and providers. He holds board positions at healthcare AI platform N1 Health and Fenway Health, and serves as an advisor to value-based care enabler Guidehealth. Named a Rising Star by Becker's Hospital Review and a 40 Under 40 by Boston Business Journal, he is a member of the Forbes Technology Council and a frequent media commentator on digital health. He holds a BA in Economics and Entrepreneurial Leadership from Tufts University.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereVector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhen a teenager expresses suicidal thoughts to an AI chatbot, what happens next?In this clip from our episode “Who Sets the Rules for AI in Medicine?”, hosts David E. Williams and John Driscoll and Dr. John Whyte, CEO of the American Medical Association, break down why minors need stronger protections from AI chatbots than adults do, and why the line between a wellness app and a medical device matters more than the industry wants to admit.Listen to the full episode here🎙️⚕️ABOUT DR. JOHN WHYTEJohn J. Whyte, MD, MPH is the CEO and Executive Vice President of the American Medical Association, the nation's largest physician organization. Prior to the AMA, he served as Chief Medical Officer at WebMD, Director of Professional Affairs and Stakeholder Engagement at the FDA's Center for Drug Evaluation and Research, Chief Medical Expert and VP of Health and Medical Education at Discovery Channel, and held a role at CMS where he helped formalize Medicare's national coverage decision process. He is a board-certified internist with an MD from Hahnemann University School of Medicine, residency training at Duke University Medical Center, and an MPH in Health Policy and Management from Harvard University. He has also served as a health services research fellow at Stanford University and is the author of five best-selling books.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailEighty-one percent of physicians are already using AI in practice, more than double the rate from just three years ago. The tools are moving faster than the rules, and nobody has agreed on who gets to write them.Dr. John Whyte, CEO of the American Medical Association, joins hosts David E. Williams and John Driscoll to discuss why the medical community needs to lead the conversation on AI guardrails rather than wait for Washington to catch up, and why the most urgent regulatory question right now involves AI chatbots in mental health, where one in six American adults are already using them with no meaningful oversight in place.🎙️⚕️ABOUT DR. JOHN WHYTEJohn J. Whyte, MD, MPH is the CEO and Executive Vice President of the American Medical Association, the nation's largest physician organization. Prior to the AMA, he served as Chief Medical Officer at WebMD, Director of Professional Affairs and Stakeholder Engagement at the FDA's Center for Drug Evaluation and Research, Chief Medical Expert and VP of Health and Medical Education at Discovery Channel, and held a role at CMS where he helped formalize Medicare's national coverage decision process. He is a board-certified internist with an MD from Hahnemann University School of Medicine, residency training at Duke University Medical Center, and an MPH in Health Policy and Management from Harvard University. He has also served as a health services research fellow at Stanford University and is the author of five best-selling books.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. ✨THIS VIDEO BROUGHT YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereVector Sciences:Dr. Dan Barouch and active angel investor and biotech lawyer Kris Brown are excited to join an upcoming CareTalk podcast discussion about the future of vaccines, biodefense preparedness, and why next-generation adenoviral and mucosal vaccine technologies may play an important role alongside mRNA approaches in addressing future global outbreaks. Looking forward to discussing how scalable, durable, and potentially transmission-blocking vaccine platforms could reshape pandemic response and global public health.Hear more about Vector Sciences hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailEighty-one percent of physicians are already using AI in practice, more than double the rate from just three years ago. The tools are moving faster than the rules, and nobody has agreed on who gets to write them.Dr. John Whyte, CEO of the American Medical Association, joins hosts David E. Williams and John Driscoll to discuss why the medical community needs to lead the conversation on AI guardrails rather than wait for Washington to catch up, and why the most urgent regulatory question right now involves AI chatbots in mental health, where one in six American adults are already using them with no meaningful oversight in place.🎙️⚕️ABOUT DR. JOHN WHYTEJohn J. Whyte, MD, MPH is the CEO and Executive Vice President of the American Medical Association, the nation's largest physician organization. Prior to the AMA, he served as Chief Medical Officer at WebMD, Director of Professional Affairs and Stakeholder Engagement at the FDA's Center for Drug Evaluation and Research, Chief Medical Expert and VP of Health and Medical Education at Discovery Channel, and held a role at CMS where he helped formalize Medicare's national coverage decision process. He is a board-certified internist with an MD from Hahnemann University School of Medicine, residency training at Duke University Medical Center, and an MPH in Health Policy and Management from Harvard University. He has also served as a health services research fellow at Stanford University and is the author of five best-selling books. 🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereVector Sciences:Vector Sciences is a BIDMC/Harvard spin out, utilizing a novel, next-generation RheoVax platform for development of improved vaccines and therapeutics.Learn how Vector Sciences is developing medicines for a healthier world, hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThere are very few cures for cancers that have already spread. So what does a good outcome actually look like?In this clip from our episode “How Targeted Radiotherapy Is Changing Cancer Care”, host David E. Williams and John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, break down what extending life with quality really means in cancer care, and why giving someone eight more months where they can still live their life is the philosophy driving the work at Ratio Therapeutics.Listen to the full episode here🎙️⚕️ABOUT JOHN BABICHJohn W. Babich, a native of New York City, holds a BS in pharmaceutical sciences from St. John’s University and a PhD in radiopharmaceutical chemistry from The Institute of Cancer Research in London. He began his career at Brookhaven National Laboratory and later NASA, focusing on cardiovascular imaging. Babich co-founded Molecular Insight Pharmaceuticals in 1998, where he developed several radiopharmaceuticals, including a PSMA inhibitor for prostate cancer now in Phase 3 trials. In 2017, he founded Noria Therapeutics, which was sold to Bayer in 2021, leading to the creation of Ratio Therapeutics.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFor decades, cancer treatment has rested on three pillars: surgery, chemotherapy, and external beam radiation. A fourth is now taking shape, and it is drawing billions in investment from some of the largest pharmaceutical companies in the world.John Babich, Founder, President, and Chief Scientific Officer of Ratio Therapeutics, joins host David E. Williams to explain how targeted radiotherapeutics pair a tumor-seeking molecule with a radioactive payload, delivering radiation to cancer cells while sparing healthy tissue. He also unpacks what Pluvicto’s success in prostate cancer signals for the future of radioligand therapy.🎙️⚕️ABOUT JOHN BABICHJohn W. Babich, a native of New York City, holds a BS in pharmaceutical sciences from St. John’s University and a PhD in radiopharmaceutical chemistry from The Institute of Cancer Research in London. He began his career at Brookhaven National Laboratory and later NASA, focusing on cardiovascular imaging. Babich co-founded Molecular Insight Pharmaceuticals in 1998, where he developed several radiopharmaceuticals, including a PSMA inhibitor for prostate cancer now in Phase 3 trials. In 2017, he founded Noria Therapeutics, which was sold to Bayer in 2021, leading to the creation of Ratio Therapeutics.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/✨THIS VIDEO BROUGHT YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereVector Sciences:Dr. Dan Barouch and active angel investor and biotech lawyer Kris Brown are excited to join an upcoming CareTalk podcast discussion about the future of vaccines, biodefense preparedness, and why next-generation adenoviral and mucosal vaccine technologies may play an important role alongside mRNA approaches in addressing future global outbreaks. Looking forward to discussing how scalable, durable, and potentially transmission-blocking vaccine platforms could reshape pandemic response and global public health.Hear more about Vector Sciences hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThe COVID-19 pandemic proved vaccine platforms can move at unprecedented speed. It also revealed how dangerously narrow the world's response really was, built almost entirely on a single technology.Dr. Dan Barouch and Kris Brown, Co-Founders of Vector Sciences, join host David E. Williams to discuss why durable pandemic preparedness depends on having multiple vaccine platforms rather than just one, how their Rheovax platform uses mucosal immunity delivered through the nose to block transmission rather than just prevent severe disease, and why public trust in vaccines depends on being honest about what each technology can and cannot actually do.🎙️⚕️ABOUT DR. DAN BAROUCHDan Barouch received his Ph.D. in immunology from Oxford University and his M.D. from Harvard Medical School. He is currently the William Bosworth Castle Professor of Medicine at Harvard Medical School, Director of the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, and a member of the Ragon Institute of MGH, MIT, and Harvard. His laboratory focuses on studying the immunology and pathogenesis of viral infections and developing novel vaccine and treatment strategies. His group has led the development of vaccine candidates for HIV-1, Zika, SARS-CoV-2, tuberculosis, and influenza. His work contributed to the development of the Johnson & Johnson COVID-19 vaccine and the evaluation of multiple COVID-19 vaccines and therapeutics. He was elected to the American Society for Clinical Investigation (2009), Association of American Physicians (2013), and National Academy of Medicine (2020), and he received the King Faisal Prize in Medicine (2023).🎙️⚕️ABOUT KRISTOPHER BROWNKristopher Brown is an active angel investor and entrepreneur who has founded several companies, including Vector Sciences, Inc., and has been the first or second angel investor in over 90 companies over the past 25 years, including Skype, Blockchain, and Compass, as well as a limited partner in a dozen earlier stage venture capital funds spanning life sciences, fintech, media, and digital healthcare. He is also a senior law partner in the Life Sciences & Technology Practice Group at Goodwin Procter LLP, where he has practiced for nearly 35 years and advised on more than 250 transactions in the life sciences sector, including mergers and acquisitions, divestitures, public offerings, licensing transactions, and the formation of investment partnerships and strategic alliances. He holds a degree in Mathematics and Economics from Brown University and a JD from Boston University School of Law, where he served as Executive Editor of the BU Law Review. 🎙️⚕️ABOUT VECTOR SCIENCESVector Sciences is a next-generation vaccine platform company focused on developing durable, scalable, and potentially transmission-blocking vaccines using its proprietary RheoVax rhesus adenovirus platform. Founded by leading virologists including Dr. Dan Barouch of Harvard’s Beth Israel Deaconess Medical Center, the company is advancing novel mucosal and intranasal vaccine approaches designed to generate strong local and systemic immunity while potentially improving ease of deployment, reducing cold-chain dependence, and lowering manufacturing complexity. Vector Sciences’ platform is being explored across multiple infectious disease applications, with the broader goal of creating safer, more effective, and more globally deployable vaccines for future pandemic and biodefense preparedness.Learn more about Vector Sciences here.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailPeople trust their doctor. They do not trust the bill they get afterward.In this clip from our episode “Why Healthcare Prices Are Like Fight Club”, host John Driscoll and Mark Cuban, Co-Founder of Cost Plus Drugs, break down why pricing transparency, not just lower prices, was the real reason Cost Plus Drugs earned the trust of patients across the country.Listen to the full episode here🎙️⚕️ABOUT MARK CUBANMark Cuban is a self-made billionaire entrepreneur known for his early tech ventures like Broadcast.com, his ownership of the Dallas Mavericks, and his role as a "Shark" on ABC's Shark Tank, investing in numerous startups and expanding into media, film, and healthcare, always championing innovation and disruption. In 2019, Mark co-founded Costplusdrugs.com with the aim of lowering generic drug prices for end consumers in the U.S., starting the company after receiving an email from a radiologist named Alex Oshmyansky, who pitched the idea of an online-based pharmacy. He often refers to Cost Plus Drugs as a critique and disruptor of the US health care system, including offering transparent, direct-to-consumer pricing and reducing the role of pharmacy benefit managers. Mark has earned a number of accolades including being named to the Texas Business Hall of Fame, the Horatio Alger Award, the SXSW Hall of Fame, Ernst and Young Entrepreneur of the Year, and GQ Man of the Year.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailNobody at the pharmacy counter knows the real price of their medication, and almost nobody in the system actually wants them to.Mark Cuban, Co-Founder of Cost Plus Drugs, joins host John Driscoll on CareTalk to discuss why pharmacy benefit managers control 85% of drug formularies in this country, how spread pricing quietly inflates the cost of everything from generics to hip replacements, and why true price transparency, not just lower prices, is the real disruption Cost Plus Drugs has brought to a $5 trillion industry.🎙️⚕️ABOUT MARK CUBANMark Cuban is a self-made billionaire entrepreneur known for his early tech ventures like Broadcast.com, his ownership of the Dallas Mavericks, and his role as a "Shark" on ABC's Shark Tank, investing in numerous startups and expanding into media, film, and healthcare, always championing innovation and disruption. In 2019, Mark co-founded Costplusdrugs.com with the aim of lowering generic drug prices for end consumers in the U.S., starting the company after receiving an email from a radiologist named Alex Oshmyansky, who pitched the idea of an online-based pharmacy. He often refers to Cost Plus Drugs as a critique and disruptor of the US health care system, including offering transparent, direct-to-consumer pricing and reducing the role of pharmacy benefit managers. Mark has earned a number of accolades including being named to the Texas Business Hall of Fame, the Horatio Alger Award, the SXSW Hall of Fame, Ernst and Young Entrepreneur of the Year, and GQ Man of the Year.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the showSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailGLP-1 drugs were designed for weight loss. Now they may be showing up in cancer research in a way nobody expected.In this clip from our episode “The Business & Science Behind the GLP-1 Boom”, hosts David E. Williams and John Driscoll break down what the 2026 ASCO annual meeting revealed about GLP-1s and their potential to reduce cancer progression in lung, breast, colorectal, and liver cancer.Listen to the full episode here🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailGLP-1 drugs have produced some of the most consistent weight loss results medicine has ever seen. The business of actually getting them to patients is a different story entirely.David E. Williams, President of Health Business Group, and John Driscoll, Chairman of UConn Health, break down the CVS Caremark formulary reversal on CareTalk, examining what it reveals about the economics of GLP-1 coverage, and why emerging clinical research on cancer, long COVID, and addiction may push these drugs far beyond their original indication.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. 🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailSix million healthcare workers are missing today. By 2030, that number reaches 10 million. No amount of training will ever close that gap.In this clip from our episode “Is AI the New Dr. Google?”, host David E. Williams and Bertalan Mesko, Director of the Medical Futurist Institute, break down why the healthcare worker shortage is a mathematical problem that only advanced technology can solve.Listen to the full episode here🎙️⚕️ABOUT DR. BERTALAN MESKODr. Bertalan Meskó, MD, PhD, widely known as "The Medical Futurist," is a leading global expert on healthcare technology. He serves as the Director of The Medical Futurist Institute and is a Private Professor at Semmelweis University in Budapest, Hungary. With a background as a physician and a PhD in genomics, Dr. Meskó focuses on how tools like artificial intelligence, wearable devices, and robots can improve modern medicine. He has delivered hundreds of keynote presentations at top institutions like Harvard and Stanford. He is also a bestselling author who has been featured by major media outlets such as CNN, TIME, and National Geographic.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThe World Health Organization projects a global shortage of 10 million healthcare workers by 2030. No training pipeline can close that gap. The only path forward runs through technology.Dr. Bertalan Meskó, Founder & Director of the Medical Futurist Institute, joins host David E. Williams to discuss why digital health is first and foremost a cultural transformation rather than a technological one, and why the most important thing any health system leader can do right now is learn how to use AI as the connective interface between an increasingly complex ecosystem of tools, patients, and clinical teams.🎙️⚕️ABOUT DR. BERTALAN MESKODr. Bertalan Meskó, MD, PhD, widely known as "The Medical Futurist," is a leading global expert on healthcare technology. He serves as the Director of The Medical Futurist Institute and is a Private Professor at Semmelweis University in Budapest, Hungary. With a background as a physician and a PhD in genomics, Dr. Meskó focuses on how tools like artificial intelligence, wearable devices, and robots can improve modern medicine. He has delivered hundreds of keynote presentations at top institutions like Harvard and Stanford. He is also a bestselling author who has been featured by major media outlets such as CNN, TIME, and National Geographic.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/🩺 THIS EPISODE IS BROUGHT TO YOU BY:PIM Health:At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone.Learn what PIM Health is building hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThe liver is the only organ in the body that can release stored glucose to prevent low blood sugar. So why has injected insulin never been able to reach it?In this clip from our episode “Finding a Solution for GLP-1 Side Effects”, host David E. Williams and Bob Geho, Founder and CEO of Diasome, break down the biological gap at the heart of diabetes treatment and how a father's decades of research into liver-targeted insulin delivery became the founding idea behind Diasome.Listen to the full episode here🎙️⚕️ABOUT BOB GEHOBob Geho is the Chief Executive Officer of Diasome Pharmaceuticals, a clinical-stage biopharmaceutical company developing portal-hepatic -targeted therapies designed to act at the source of metabolic regulation.Under his leadership, Diasome is advancing its proprietary Hepatocyte-Directed Vesicle (HDV) platform, which targets liver hepatocytes and the portal hepatic region, where metabolic control is centered. The company's lead clinical program, HDV-Insulin, applies this approach to insulin therapy — grounded in the principle that therapies working with the body's natural physiology may produce meaningfully better outcomes. The HDV platform is also being explored across GLP-1 and serotonin programs.Bob's work in hepatic-directed drug delivery spans more than three decades, including helping lead the first successful human clinical study of liver-targeted insulin in Type 1 diabetes patients. He co-founded Diasome in 2004 and has since guided the company through multiple rounds of financing and into clinical development. He also co-founded SDG, Inc., a Cleveland-based holding company that has supported the creation of multiple life sciences startups and strategic partnerships.He holds an MBA from Case Western Reserve University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailEvery year, one in five adults with Type 1 diabetes experiences a dangerous drop in blood sugar that renders them unable to treat themselves. These severe hypoglycemic events are still happening, even though many patients now use continuous glucose monitors and automated insulin pumps.Why has this trade-off between long-term A1C control and dangerous sugar crashes persisted for over 30 years?Bob Geho, Founder and CEO of Diasome, joins host David E. Williams to unpack the results of the company’s 200+ patient Phase 2B OPTI-2 trial of HDV™ insulin. The study was presented recently at the American Diabetes Association meeting in New Orleans.In the trial, five patients using standard insulin experienced severe hypoglycemic events. This compares with zero such events among patients receiving HDV™ insulin. Meanwhile, HDV™ insulin matched standard-of-care A1C control.Bob also shares how the HDV platform is being studied for its potential to reduce side effects in GLP-1 therapy and to address insulin resistance, considered the root cause of Type 2 Diabetes.🎙️⚕️ABOUT BOB GEHOBob Geho is the Chief Executive Officer of Diasome Pharmaceuticals, a clinical-stage biopharmaceutical company developing portal-hepatic -targeted therapies designed to act at the source of metabolic regulation.Under his leadership, Diasome is advancing its proprietary Hepatocyte-Directed Vesicle (HDV) platform, which targets liver hepatocytes and the portal hepatic region, where metabolic control is centered. The company's lead clinical program, HDV-Insulin, applies this approach to insulin therapy — grounded in the principle that therapies working with the body's natural physiology may produce meaningfully better outcomes. The HDV platform is also being explored across GLP-1 and serotonin programs.Bob's work in hepatic-directed drug delivery spans more than three decades, including helping lead the first successful human clinical study of liver-targeted insulin in Type 1 diabetes patients. He co-founded Diasome in 2004 and has since guided the company through multiple rounds of financing and into clinical development. He also co-founded SDG, Inc., a Cleveland-based holding company that has supported the creation of multiple life sciences startups and strategic partnerships.He holds an MBA from Case Western Reserve University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work at healthbusinessgroup.com/GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailAmerican hospitals now spend nearly $2 on administrative overhead for every dollar that touches direct patient care. Insurers earn billions in float by sitting on claims for weeks, providers borrow money just to stay liquid, and patients open bills for visits they barely remember.Don Peterson, Founder and CEO of PIM Health, joins host David E. Williams to discuss why healthcare's payment system is working exactly as it was designed to work, and how real-time claims adjudication at the point of care could eliminate prior authorization as it currently exists, cut administrative overhead from 12 to 15 percent down to 2 to 3 percent, and return hundreds of billions of dollars in waste back to patients, providers, and plan sponsors.🎙️⚕️ABOUT DON PETERSONDon Peterson is a healthcare entrepreneur and technology executive with over 30 years of experience building and scaling companies across technology and healthcare. He held senior roles at AMD during the semiconductor boom, founded DeskStation Technology in 1990 (acquired by Samsung), and in 2012 founded IVX Health, building the operating model for ambulatory infusion centers from the ground up. Under subsequent leadership, IVX Health scaled to 150+ locations nationally and completed a change-of-control transaction in 2024 at a valuation exceeding one billion dollars. Peterson also launched and operationalized ambulatory infusion clinics in Saudi Arabia from 2020 to 2024.He is currently the founder of PIM Health Corp., a healthcare technology company developing real-time claims adjudication and payment infrastructure designed to replace the batch-processing architecture that has defined healthcare payment settlement for decades. Peterson publishes healthcare policy analysis and industry commentary on Substack and hosts the podcast Divided Attention, covering healthcare, technology, and policy.🎙️⚕️ABOUT PIM HEALTHPIM Health is a healthcare technology company building real-time claims adjudication and payment infrastructure designed to replace the batch-processing architecture that has defined healthcare payment settlement for decades. Founded by Don Peterson, whose experience scaling IVX Health to a billion-dollar acquisition gave him a firsthand view of how broken healthcare payment actually is, PIM is built around a simple insight: providers who get paid in 24 hours instead of 90 days, members who never receive a surprise bill, and self-insured employers who can see real-time claims activity will drive demand faster than any direct sales effort. The infrastructure investment by payers follows that demand, not the other way around.At PIM Health, we’re building real-time payment infrastructure where providers don’t wait weeks to get paid, patients don’t leave without knowing exactly what they owe, and employers stop flying blind on their own plan spend. AR burden, gone. Surprise bills, gone. Prior auth delays, gone. Denials and appeals, gone. Learn what we’re building at pim.health🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhat if the tools patients use between therapy sessions mattered more than the sessions themselves?In this clip from our episode “Fixing the Access Crisis In Mental Health”, host John Driscoll and Mark Frank, Co-Founder and CEO of SonderMind, break down how a fully integrated platform combining 80 digital interventions with an AI coach is producing outcomes up to 275% better than traditional therapy alone.Listen to the full episode here🎙️⚕️ABOUT MARK FRANKAs the CEO and co-founder of SonderMind, I lead a fast-growing and compassionate team whose mission is to redesign behavioral health to increase access, expand utilization and improve clinical outcomes. Our focus is to democratize behavioral healthcare for both patients and practitioners, by making it easy to access therapists with the right expertise, making it convenient by offering online or in person treatment, and making it affordable by matching patients with highly qualified providers that deliver the most effective care. I believe in leading with transparency, empathy, and courage, and my passion is to build an organization that has a positive and transformative effect on the field of behavioral health and ultimately the entire healthcare ecosystem.Prior to founding SonderMind in 2015, I helped found three other successful ventures, including Next Oncology, TermScout and SafeImageMD. Prior to my career as an entrepreneur, I worked in healthcare investment banking at Morgan Stanley, as well as time with Lehman Brothers and CDI Global. Prior to my business career, I served as an officer in the US Army. During and after that time in the military, I saw friends and colleagues return from deployments and struggle to access appropriate mental health care. This experience shaped and strengthened my commitment to enhancing access to therapy to improve and enrich people’s lives.I have a Bachelor's Degree in Computer Science from the United States Military Academy at West Point, a Masters in Computer Information Systems from the University of Phoenix, a Masters of Engineering Management from Northwestern University, and an MBA in Finance and Operations from the Kellogg School of Management at Northwestern University.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailMore than 160 million Americans live in federally designated mental health provider shortage areas. Even those with insurance often spend months searching for a therapist who takes their plan and has availability.Mark Frank, Co-Founder and CEO of SonderMind, joins host John Driscoll to discuss why fixing the provider infrastructure had to come before solving patient access, and how a fully integrated platform combining measurement-based care with AI-powered tools between sessions is producing outcomes up to 275% better than traditional therapy alone.🎙️⚕️ABOUT MARK FRANKAs the CEO and co-founder of SonderMind, I lead a fast-growing and compassionate team whose mission is to redesign behavioral health to increase access, expand utilization and improve clinical outcomes. Our focus is to democratize behavioral healthcare for both patients and practitioners, by making it easy to access therapists with the right expertise, making it convenient by offering online or in person treatment, and making it affordable by matching patients with highly qualified providers that deliver the most effective care. I believe in leading with transparency, empathy, and courage, and my passion is to build an organization that has a positive and transformative effect on the field of behavioral health and ultimately the entire healthcare ecosystem.Prior to founding SonderMind in 2015, I helped found three other successful ventures, including Next Oncology, TermScout and SafeImageMD. Prior to my career as an entrepreneur, I worked in healthcare investment banking at Morgan Stanley, as well as time with Lehman Brothers and CDI Global. Prior to my business career, I served as an officer in the US Army. During and after that time in the military, I saw friends and colleagues return from deployments and struggle to access appropriate mental health care. This experience shaped and strengthened my commitment to enhancing access to therapy to improve and enrich people’s lives.I have a Bachelor's Degree in Computer Science from the United States Military Academy at West Point, a Masters in Computer Information Systems from the University of Phoenix, a Masters of Engineering Management from Northwestern University, and an MBA in Finance and Operations from the Kellogg School of Management at Northwestern University.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFor most small businesses, health insurance is their second or third largest expense. And they usually find out what it's going to cost them two to three weeks before renewal.In this clip from our episode “Why Health Insurance Needs Transparency”, host John Driscoll and Ty Wang, Co-Founder and CEO of Angle Health, break down why unpredictable premium increases make it nearly impossible for small businesses to plan, and why the market has accepted this as normal for far too long.Listen to the full episode here🎙️⚕️ABOUT TY WANGTy Wang is the co-founder and CEO of Angle Health, the first AI-native healthcare benefits platform built to give SMBs access to quality health plans.Ty grew up in an immigrant family, where access to healthcare and healthcare literacy were significant challenges. He founded Angle Health to address these issues, focusing on providing transparency and simplicity in the healthcare system. Today, Angle Health partners with thousands of brokers and employers across the U.S., primarily serving small- and medium-sized businesses to offer affordable, high-quality healthcare coverage to tens of thousands of Americans.Prior to founding Angle Health, Ty led major deployments at Palantir Technologies and spent several years in public service with the U.S. government across various foreign and domestic posts. He graduated from Washington University in St. Louis with degrees in electrical engineering and systems engineering.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailNearly half of all Americans get their health insurance through a small business. Most of those businesses have no idea why their premiums go up every year and no real power to do anything about it.Ty Wang, Co-Founder and CEO of Angle Health, joins host John Driscoll to discuss why legacy insurers benefit from keeping small businesses in the dark on costs, and how rebuilding the health plan stack from the ground up on modern, AI-native infrastructure is finally making transparency and customization possible for the employers who have always needed it most.🎙️⚕️ABOUT TY WANGTy Wang is the co-founder and CEO of Angle Health, the first AI-native healthcare benefits platform built to give SMBs access to quality health plans.Ty grew up in an immigrant family, where access to healthcare and healthcare literacy were significant challenges. He founded Angle Health to address these issues, focusing on providing transparency and simplicity in the healthcare system. Today, Angle Health partners with thousands of brokers and employers across the U.S., primarily serving small- and medium-sized businesses to offer affordable, high-quality healthcare coverage to tens of thousands of Americans.Prior to founding Angle Health, Ty led major deployments at Palantir Technologies and spent several years in public service with the U.S. government across various foreign and domestic posts. He graduated from Washington University in St. Louis with degrees in electrical engineering and systems engineering.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFor years, hospitals managing value-based contracts have been doing so with one hand tied behind their back, defaulting to Medicare logic because that was the only playbook precise enough to follow.In this clip from our episode “Why Value-Based Care Is Finally Hitting Its Tipping Point”, host David E. Williams and David Snow, Chairman & CEO of Cedar Gate Technologies, an IQVIA business, break down why that era of generalization is over and what precision contract analytics actually makes possible now.Listen to the full episode here🎙️⚕️ABOUT DAVID SNOWDavid Snow is a nationally recognized healthcare executive with 40 years of experience leading Fortune 50 companies, health plans, hospitals, and innovative healthcare startups. He has been named one of America's Best CEOs by Institutional Investor and ranked #27 on the Harvard Business Review's list of Best Performing CEOs in the World.He is currently the Founder, Chairman, and CEO of Cedar Gate Technologies, a provider of technology-powered end-to-end solutions designed to enable success in value-based care. Prior to Cedar Gate, Snow served as Chairman and CEO of Medco Health Solutions, a Fortune 34 company, which he took public in 2003 and grew from $30 billion to $72 billion in revenue over nine years.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work here.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFor decades, value-based care has been healthcare's promised future. Most health systems have stayed in upside-only arrangements, and the data infrastructure needed to manage real risk has never quite caught up to the ambition.That may finally be changing. David Snow, Chairman & CEO of Cedar Gate Technologies, an IQVIA business, joins host David E. Williams to discuss why CMS's first mandatory bundled payment model signals the end of voluntary experimentation, and why the fragmented data problem that has undermined value-based care for a generation is only now finding a real solution.🎙️⚕️ABOUT DAVID SNOWDavid Snow is a nationally recognized healthcare executive with 40 years of experience leading Fortune 50 companies, health plans, hospitals, and innovative healthcare startups. He has been named one of America's Best CEOs by Institutional Investor and ranked #27 on the Harvard Business Review's list of Best Performing CEOs in the World.He is currently the Founder, Chairman, and CEO of Cedar Gate Technologies, a provider of technology-powered end-to-end solutions designed to enable success in value-based care. Prior to Cedar Gate, Snow served as Chairman and CEO of Medco Health Solutions, a Fortune 34 company, which he took public in 2003 and grew from $30 billion to $72 billion in revenue over nine years.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work here.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIs it easier to change the medical establishment from the inside or the outside?In this clip from our episode "MAHA Split Over New Surgeon General," hosts David E. Williams and John Driscoll break down what separated Casey Means from Nicole Saphier, and why the switch from outsider advocate to credentialed insider may say everything about how health reform actually gets done.Listen to the full episode here🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailThe collapse of Dr. Casey Means’ nomination this week has sent shockwaves through the “Make America Healthy Again” (MAHA) movement. While the tech world debates AI, healthcare is debating the “Saphier Pivot,” the Trump administration’s sudden shift from a radical MAHA outsider to a credentialed Fox News regular. With the Surgeon General’s office at a crossroads, we have to ask: is the role still a beacon of public health, or has it become the ultimate prize in the culture war?John Driscoll, Chairman of UConn Health and David E. Williams, President of Health Business Group, diagnose the state of the Surgeon General's office, examining what the rapid pivot to Dr. Nicole Saphier reveals about the limits of MAHA's political power, and whether the nation's most visible public health platform can still move the needle in an era of historic distrust in federal health agencies.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIs American healthcare collapsing?In this clip from our episode "How AI Could Save a Collapsing Healthcare System," host David E. Williams and Dr. Robert Pearl, Author of ChatGPT MD, break down why the current system is financially unsustainable and why physicians have never had the tools to fight back. Until now.Listen to the full episode here🎙️⚕️ABOUT DR. ROBERT PEARLRobert Pearl, MD served as CEO of The Permanente Medical Group (Kaiser Permanente) for 18 years and former president of The Mid-Atlantic Permanente Medical Group, leading 10,000 physicians and 38,000 staff responsible for the care of 5 million Kaiser Permanente members on the west and east coasts. He is a clinical professor of plastic surgery at Stanford University School of Medicine and faculty at the Stanford Graduate School of Business, teaching healthcare strategy, technology, and leadership. Pearl is board certified in plastic and reconstructive surgery, with his medical degree from Yale and residency at Stanford.He is the author of three books: Mistreated: Why We Think We're Getting Good Healthcare—And Why We're Usually Wrong, a Washington Post bestseller (2017); Uncaring: How the Culture of Medicine Kills Doctors & Patients, a Kirkus star recipient (2021); and ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine (April 2024). All profits go to Doctors Without Borders.Pearl is a LinkedIn Top Voice in healthcare and host of the podcasts Fixing Healthcare and Medicine: The Truth, with two monthly newsletters reaching 50,000+ combined subscribers. He has presented at The World Healthcare Congress, the Commonwealth Club, TEDx, HLTH, NCQA Quality Talks, the National Primary Care Transformation Summit, and international conferences in Brazil, Australia, India, and beyond. His insights on generative AI have been featured in Associated Press, USA Today, Forbes, Fast Company, WIRED, Modern Healthcare, Medscape, Becker's Hospital Review, the Advisory Board, and the Journal of AHIMA.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailAmerican employers now spend over $25,000 a year to cover a single family, and chronic disease is driving the system toward collapse. Yet medicine is still built around a doctor's office visit every three to four months.Dr. Robert Pearl, former CEO of the Permanente Medical Group, Stanford professor, and author of ChatGPT MD, joins host David E. Williams to make the case that generative AI is the only tool that can shift medicine from episodic to continuous care, and why without it, the chronic disease crisis will break American healthcare entirely.🎙️⚕️ABOUT DR. ROBERT PEARLRobert Pearl, MD served as CEO of The Permanente Medical Group (Kaiser Permanente) for 18 years and former president of The Mid-Atlantic Permanente Medical Group, leading 10,000 physicians and 38,000 staff responsible for the care of 5 million Kaiser Permanente members on the west and east coasts. He is a clinical professor of plastic surgery at Stanford University School of Medicine and faculty at the Stanford Graduate School of Business, teaching healthcare strategy, technology, and leadership. Pearl is board certified in plastic and reconstructive surgery, with his medical degree from Yale and residency at Stanford.He is the author of three books: Mistreated: Why We Think We're Getting Good Healthcare—And Why We're Usually Wrong, a Washington Post bestseller (2017); Uncaring: How the Culture of Medicine Kills Doctors & Patients, a Kirkus star recipient (2021); and ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine (April 2024). All profits go to Doctors Without Borders.Pearl is a LinkedIn Top Voice in healthcare and host of the podcasts Fixing Healthcare and Medicine: The Truth, with two monthly newsletters reaching 50,000+ combined subscribers. He has presented at The World Healthcare Congress, the Commonwealth Club, TEDx, HLTH, NCQA Quality Talks, and international conferences in Brazil, Australia, and India. His insights on generative AI have been featured in Associated Press, USA Today, Forbes, Fast Company, WIRED, Modern Healthcare, Medscape, Becker's Hospital Review, the Advisory Board, and the Journal of AHIMA.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.Need a Strategy Partner?For over 20 years, Health Business Group has helped healthcare software companies, tech-enabled services businesses, life sciences companies, and payers make smarter strategic decisions. Led by podcast host David Williams, the firm advises clients on sharpening AI positioning, entering new segments, and building commercial strategies for value-based care. See examples of our work hereGET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIs the era of just managing Parkinson's symptoms finally coming to an end?In this clip from our episode “How AI Is Helping The Fight Against Parkinson’s”, host David E. Williams and guest Gene Mack, CEO of Gain Therapeutics, share why the early signals from their lead drug candidate are too compelling to ignore.Listen to the full episode here🎙️⚕️ABOUT GENE MACKGene Mack serves as Chief Executive Officer and President of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023. Previous to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $475 million acquisition of OncoImmune in 2020 where he had also been CFO. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $350 million in IPO and other equity transactions. Prior to his operational experience, Gene covered the biotechnology and life sciences sector as a senior publishing analyst at various investment banks, including Gruntal & Co, Lazard, Mizuho, and HSBC. Gene received both his B.S. in Biochemistry and M.B.A. in Finance from Fordham University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFor decades, Parkinson's patients have been offered only symptom management. No drug has ever slowed the disease itself. A small clinical stage biotech may be about to change that.Gene Mack, CEO, Gain Therapeutics joins host David E. Williams to discuss the science behind a potential first disease modifying therapy for Parkinson's, how AI is accelerating drug discovery, and what it takes to build a biotech in one of the toughest capital markets in years.🎙️⚕️ABOUT GENE MACKGene Mack serves as Chief Executive Officer and President of Gain Therapeutics. He joined the Company in April 2024 and brings 25 years of experience in the life sciences sector spanning clinical research, financing and capital markets, investing, corporate strategy and business development. Prior to joining Gain, Gene was CFO at privately held Imcyse SA between 2021 and 2023. Previous to Imcyse, Gene was CFO at OncoC4, a privately held biotechnology company that spun out of Merck & Co’s (MSD) $475 million acquisition of OncoImmune in 2020 where he had also been CFO. Before that, he has held the CFO role for several development- and commercial-stage biopharmaceutical companies, raising over $350 million in IPO and other equity transactions. Prior to his operational experience, Gene covered the biotechnology and life sciences sector as a senior publishing analyst at various investment banks, including Gruntal & Co, Lazard, Mizuho, and HSBC. Gene received both his B.S. in Biochemistry and M.B.A. in Finance from Fordham University.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIf you or someone you love just received a cancer diagnosis, what are the first three things you need to know?In this clip from our episode “Can AI Help Us Finally Beat Cancer”, host John Driscoll and guest Dr. Sanjay Juneja, TheOncDoc, walk through the essential steps every cancer patient should take immediately after diagnosis.Listen to the full episode here🎙️⚕️ABOUT SANJAY JUNEJA, MDDr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 50 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim. His debut podcast, Target Cancer: Podcast, amassed 4+ million downloads in over 120 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests.Dr. Juneja’s accolades include being named Targeted Oncology’s inaugural 2024 Oncology Icon, an invitation to the White House’s 2023 Healthcare Leaders in Social Media Roundtable, and recognition as a 40 Under 40 honoree and one of the Capital Region’s Top 500 Most Influential Leaders for three consecutive years. His insights have been featured in The Washington Post, WIRED, Bloomberg, and PBS.In addition to founding TensorBlack, an educational platform specializing in AI applications in oncology, Dr. Juneja serves as Vice President of Clinical AI Operations at Tempus AI and a contributing writer + Technology council for Forbes.  He is credentialed by Harvard Medical School’s inaugural AI in Healthcare: From Strategies to Implementation Executive Education, and an Editorial Board Member for the peer-reviewed journal AI in Precision Oncology.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailA cancer diagnosis doesn't have to feel like a death sentence. The science is advancing faster than most people realize, and what patients know about their own diagnosis can change everything.Dr. Sanjay Juneja, TheOncDoc joins host John Driscoll to discuss why cancer is increasingly a manageable disease, how patient empowerment and early detection are shifting outcomes, and what everyone can do right now to reduce their cancer risk.🎙️⚕️ABOUT SANJAY JUNEJA, MDDr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine. Garnering over 750k followers and 50 million views on social media, Dr. Juneja’s unique ability to simplify complex topics has earned him global acclaim. His debut podcast, Target Cancer: Podcast, amassed 4+ million downloads in over 120 countries within just two years, setting the stage for his current AI-focused series featuring world-renowned guests.Dr. Juneja’s accolades include being named Targeted Oncology’s inaugural 2024 Oncology Icon, an invitation to the White House’s 2023 Healthcare Leaders in Social Media Roundtable, and recognition as a 40 Under 40 honoree and one of the Capital Region’s Top 500 Most Influential Leaders for three consecutive years. His insights have been featured in The Washington Post, WIRED, Bloomberg, and PBS.In addition to founding TensorBlack, an educational platform specializing in AI applications in oncology, Dr. Juneja serves as Vice President of Clinical AI Operations at Tempus AI and a contributing writer + Technology council for Forbes.  He is credentialed by Harvard Medical School’s inaugural AI in Healthcare: From Strategies to Implementation Executive Education, and an Editorial Board Member for the peer-reviewed journal AI in Precision Oncology.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhy does it take five years to diagnose a child with a genetic disease when the answer is available in 48 hours?In this clip from our episode “How Genomics Is Transforming Rare Disease Care”, host John Driscoll and guest Katherine Stueland, CEO of GeneDx, expose one of the most frustrating gaps in pediatric medicine today.Check out the full episode here🎙️⚕️ABOUT KATHERINE STUELANDKatherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her career has spanned supporting the FDA approval of several rare disease therapeutics, the first protease inhibitor for HIV/AIDS and the first cancer immunotherapy, all in partnership with the powerful voices of patient advocates. Katherine has been a central figure in moving healthcare forward by integrating genomic information to enhance the accuracy and effectiveness of diagnosing cancer and rare diseases.In June 2021, Katherine was named President and CEO of GeneDx (Nasdaq: WGS), a company that emerged from the National Institutes of Health and today is transforming healthcare through genomic insights with a mission to empower everyone to live their healthiest lives through the power of genomics. GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and drive drug discovery. Since joining GeneDx, she focused the business on its industry-leading exome and genome testing and interpretation products, fueled by GeneDx Infinity™ the world’s largest genomic rare disease data set. Under Katherine’s leadership, GeneDx has nearly tripled its sequencing capacity, completing over 1 million exomes and genomes while achieving profitability.Recognized for these achievements, Katherine was named the 2026 TIME100 Health list, honoring the world’s most influential health leaders. In 2025 she was also named to CNBC Changemakers: Women Transforming Business List, and GeneDx was named of Fast Company Most Innovative Companies. In 2023, Fierce Pharma recognized Katherine as one of the most influential people in biotech.Katherine serves on the Board of Directors for the American Clinical Laboratory Association (ACLA), the national trade association for leading laboratories, advancing policies that improve patient outcomes, expand access to high-quality diagnostics, and enable personalized care. She also serves on the JED Foundation Leadership Council, a nonprofit organization that works to prevent suicide and protect the emotional health of young adults and teens as part of her lifetime commitment to help improve mental health. Katherine graduated from Miami University in Oxford, Ohio, with a bachelor’s degree in science and English literature.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailOne in six children has a developmental delay, and it takes an average of five years to get a diagnosis for a genetic disease. But it doesn't have to. The technology to get answers in 48 hours already exists.Katherine Stueland, CEO, GeneDx joins host John Driscoll to discuss why rare genetic diseases are far more common than most people realize, how whole genome sequencing is transforming pediatric care, and what it will take to bring precision medicine to every child who needs it.🎙️⚕️ABOUT KATHERINE STUELANDKatherine Stueland has dedicated her career to transforming healthcare by leading patient-centric businesses. Her career has spanned supporting the FDA approval of several rare disease therapeutics, the first protease inhibitor for HIV/AIDS and the first cancer immunotherapy, all in partnership with the powerful voices of patient advocates. Katherine has been a central figure in moving healthcare forward by integrating genomic information to enhance the accuracy and effectiveness of diagnosing cancer and rare diseases.In June 2021, Katherine was named President and CEO of GeneDx (Nasdaq: WGS), a company that emerged from the National Institutes of Health and today is transforming healthcare through genomic insights with a mission to empower everyone to live their healthiest lives through the power of genomics. GeneDx delivers personalized and actionable health insights to inform diagnosis, direct treatment and drive drug discovery. Since joining GeneDx, she focused the business on its industry-leading exome and genome testing and interpretation products, fueled by GeneDx Infinity™ the world’s largest genomic rare disease data set. Under Katherine’s leadership, GeneDx has nearly tripled its sequencing capacity, completing over 1 million exomes and genomes while achieving profitability.Recognized for these achievements, Katherine was named the 2026 TIME100 Health list, honoring the world’s most influential health leaders. In 2025 she was also named to CNBC Changemakers: Women Transforming Business List, and GeneDx was named of Fast Company Most Innovative Companies. In 2023, Fierce Pharma recognized Katherine as one of the most influential people in biotech.Katherine serves on the Board of Directors for the American Clinical Laboratory Association (ACLA), the national trade association for leading laboratories, advancing policies that improve patient outcomes, expand access to high-quality diagnostics, and enable personalized care. She also serves on the JED Foundation Leadership Council, a nonprofit organization that works to prevent suicide and protect the emotional health of young adults and teens as part of her lifetime commitment to help improve mental health. Katherine graduated from Miami University in Oxford, Ohio, with a bachelor’s degree in science and English literature.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailWhat if food worked better than medication for managing diabetes?In this clip from our episode “Food As Medicine: From Trend to Treatment”, CareTalk host John Driscoll and guest Spencer Pratt, Chief Growth Officer at NourishedRx, share the clinical data behind their food as medicine approach to diabetes care.Check out the full episode here🎙️⚕️ABOUT SPENCER PRATTSpencer is Chief Growth Officer at NourishedRx. He is a leader in developing innovative frameworks and solutions for addressing social drivers of health, health equity, and population health.Prior to joining NourishedRx, Spencer held leadership roles at Unite Us and Carrot Health and established a consumer insights solution at Optum. He takes an innovative and customer-centric approach to ensure value creation and exceptional experience for healthcare organizations and members.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailFood as medicine is moving from buzzword to real healthcare strategy.In this CareTalk episode, Spencer Pratt, Chief Growth Officer of NourishedRx, explains why nutrition is finally getting the policy, payer, and consumer support needed to impact chronic disease at scale.🎙️⚕️ABOUT SPENCER PRATTSpencer is Chief Growth Officer at NourishedRx. He is a leader in developing innovative frameworks and solutions for addressing social drivers of health, health equity, and population health.Prior to joining NourishedRx, Spencer held leadership roles at Unite Us and Carrot Health and established a consumer insights solution at Optum. He takes an innovative and customer-centric approach to ensure value creation and exceptional experience for healthcare organizations and members.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIs American primary care already past the point of no return?In this clip from our episode “Why US Healthcare is Fundamentally Broken”, host David E. Williams and guest Zeev Neuwirth, Head of Strategic Partnerships at Rezilient Health, confront a stark reality about where primary care spending stands today.Check out the full episode here🎙️⚕️ABOUT ZEEV NEUWIRTH, MDFor the past 30 years, his work has been centered around humanizing healthcare, making it more affordable, accessible, equitable, and effective for all people. Strategically, his approach is to leverage digital technologies, data analytics, and consumer-centric business models to create sustainable, scalable solutions. He believes it is critical that we drive towards an integrated healthcare delivery system built upon preventive primary & population-based healthcare.In addition to his industry work, he has published two Amazon best-selling books - "Reframing Healthcare: A Roadmap For Creating Disruptive Change" and "Beyond the Walls: Megatrends, Movements, and Market Disruptors Transforming American Healthcare." His podcast, "Creating a New Healthcare" is now in its ninth year with over 200 posted episodes. These efforts are all in service of reorienting the way individuals and organizations think about healthcare, and redirecting resources and efforts to catalyze movement towards a system that delivers the healthcare and health outcomes that people want and need.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailPrimary care is on life support. Administrative burden is crushing physicians, employer healthcare is broken, and decades of reform efforts have barely moved the needle. So what does real transformation actually look like?Zeev Neuwirth, Head of Strategic Partnerships, Rezilient Health joins host David E. Williams to discuss why the American healthcare system keeps failing despite enormous resources, what direct primary care and employer contracting can do differently, and why GLP-1s without lifestyle medicine may be a costly mistake.🎙️⚕️ABOUT ZEEV NEUWIRTH, MDFor the past 30 years, his work has been centered around humanizing healthcare, making it more affordable, accessible, equitable, and effective for all people. Strategically, his approach is to leverage digital technologies, data analytics, and consumer-centric business models to create sustainable, scalable solutions. He believes it is critical that we drive towards an integrated healthcare delivery system built upon preventive primary & population-based healthcare. In addition to his industry work, he has published two Amazon best-selling books - "Reframing Healthcare: A Roadmap For Creating Disruptive Change" and "Beyond the Walls: Megatrends, Movements, and Market Disruptors Transforming American Healthcare." His podcast, "Creating a New Healthcare" is now in its ninth year with over 200 posted episodes. These efforts are all in service of reorienting the way individuals and organizations think about healthcare, and redirecting resources and efforts to catalyze movement towards a system that delivers the healthcare and health outcomes that people want and need.🎙️⚕️ABOUT HEALTH BIZ PODCASTHealthBiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.

Send us Fan MailIs this AI moment in healthcare really different from all the hype that came before?In this clip from our episode “A Brief History of AI in Healthcare”, Lekan Wang, Partner at JSL Health Capital, makes his case for why the data is finally backing up the optimism.Check out the full episode here🎙️⚕️ABOUT LEKAN WANGLekan Wang is a partner at JSL Health Capital, an AI first healthcare investment fund that is joining with some of the cutting edge companies that are leveraging technology in advancing healthcare and  hopefully creating better outcomes at lower costs.🎙️⚕️ABOUT CARETALKCareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy. GET IN TOUCHFollow CareTalk on LinkedInBecome a CareTalk sponsorGuest appearance requestsVisit us on the webSubscribe to the CareTalk NewsletterSupport the show⚙️CareTalk:  Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.